Submit News | Submit Press Releases | Create Profile | News Pricing | Become an Affiliate | RSS | Alerts | WooEB    
Business News

Algeta ASA (OSE:ALGETA) to Release Q3 2009 Earnings November 13

Ft Lauderdale, Florida 11/10/2009 12:10 AM GMT (TransWorldNews)

 

Algeta ASA (OSE:ALGETA) will release the third quarter earnings for 2009 on Friday, November 13.  The financial results will be posted on the company’s website at www.algeta.com on the Investors page.  Algeta management will host a conference at 2:30 pm CET to discuss the financial results.  Joining the call will be President and CEO Andrew Kay, CTO Thomas Ramdahl, and CFO Oystein Soug.  Those interested in participating in the call may dial 800.80.119 (Norway) or 47.23.00.04.00 (all other countries).  Interested parties who are unable to join the call may hear a replay of the presentation by dialing47.67.89.40.91 and entering the account number 1428#.  The listener will be prompted to press 1 and then to enter the conference number 428#, then 1 to play.  The replay will also be available on the company’s website.

 

Simply Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.

Sign Up for our Free Stock Newsletter

 

Algeta ASA is a Norway-based therapeutics company specializing in nuclear medicine and oncology. The Company’s activities include the development of products and radiopharmaceuticals, based on alpha particle emitters to destroy cancer cells, for the treatment of bone metastases and disseminated tumor types. The Company’s main product candidate, Alpharadin is used for targeting bone metastases resulting from such major cancers as hormone-refractory prostate, breast, lung, kidney and thyroid. Additionally, the Company is recruiting patients for Apharadin’s phase III study, which began in 2008. The Company is also involved in the research and development of the TH-1 preclinical program, where the alpha-emitting radionuclide thorium-227 is linked to cancer-seeking antibodies. As of December 31, 2008, the Company had two wholly owned subsidiaries. The Company collaborates with researchers at The Norwegian Radium Hospital in Oslo, Norway.

 

Sign up for the free Simply Best Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

 

Follow Simply Best Penny Stocks on Twitter: http://www.Twitter.com/simplybestps

 

About Us

 

Simply Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer.

 

 

info@simplybestpennystocks.com
www.simplybestpennystocks.com

Empty Image

Empty Image

   |    View Profile

Visit Blogs                           |    Bookmark and Share

Empty Image

NEWS ALERTS

Receive alerts for Simply Best Penny Stocks to your inbox. Sign up for TransWorldNews Alerts

Empty Image